269 related articles for article (PubMed ID: 24106610)
1. Von Willebrand factor, angiodysplasia and angiogenesis.
Randi AM; Laffan MA; Starke RD
Mediterr J Hematol Infect Dis; 2013 Sep; 5(1):e2013060. PubMed ID: 24106610
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations.
Ocran E; Chornenki NLJ; Bowman M; Sholzberg M; James P
Expert Rev Hematol; 2023; 16(8):575-584. PubMed ID: 37278227
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor regulation of blood vessel formation.
Randi AM; Smith KE; Castaman G
Blood; 2018 Jul; 132(2):132-140. PubMed ID: 29866817
[TBL] [Abstract][Full Text] [Related]
4. Endothelial von Willebrand factor regulates angiogenesis.
Starke RD; Ferraro F; Paschalaki KE; Dryden NH; McKinnon TA; Sutton RE; Payne EM; Haskard DO; Hughes AD; Cutler DF; Laffan MA; Randi AM
Blood; 2011 Jan; 117(3):1071-80. PubMed ID: 21048155
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor and angiogenesis: basic and applied issues.
Randi AM; Laffan MA
J Thromb Haemost; 2017 Jan; 15(1):13-20. PubMed ID: 27778439
[TBL] [Abstract][Full Text] [Related]
6. [Association between von Willebrand disease and angiodysplasia].
Salinas Laval J; Triantafilo N; Zúñiga P
Rev Med Chil; 2020 Oct; 148(10):1475-1480. PubMed ID: 33844718
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction in von Willebrand disease: angiogenesis and angiodysplasia.
Randi AM
Thromb Res; 2016 May; 141 Suppl 2():S55-8. PubMed ID: 27207426
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a Porcine Model for Von Willebrand Disease Type 1 and 3 Regarding Expression of Angiogenic Mediators in the Nonpregnant Female Reproductive Tract.
Allerkamp H; Lehner S; Ekhlasi-Hundrieser M; Detering C; Pfarrer C; Depka Prondzinski MV
Comp Med; 2019 Oct; 69(5):401-412. PubMed ID: 31526432
[TBL] [Abstract][Full Text] [Related]
9. Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor.
Inbal A; Bank I; Zivelin A; Varon D; Dardik R; Shapiro R; Rosenthal E; Shenkman B; Gitel S; Seligsohn U
Br J Haematol; 1997 Jan; 96(1):179-82. PubMed ID: 9012706
[TBL] [Abstract][Full Text] [Related]
10. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
[TBL] [Abstract][Full Text] [Related]
11. Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study.
Groeneveld DJ; Sanders YV; Adelmeijer J; Mauser-Bunschoten EP; van der Bom JG; Cnossen MH; Fijnvandraat K; Laros-van Gorkom BAP; Meijer K; Lisman T; Eikenboom J; Leebeek FWG
Thromb Haemost; 2018 Jan; 118(1):152-160. PubMed ID: 29304535
[TBL] [Abstract][Full Text] [Related]
12. Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients.
Selvam SN; Casey LJ; Bowman ML; Hawke LG; Longmore AJ; Mewburn J; Ormiston ML; Archer SL; Maurice DH; James P
Blood Coagul Fibrinolysis; 2017 Oct; 28(7):521-533. PubMed ID: 28362648
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
14. Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.
Selvam S; James P
Semin Thromb Hemost; 2017 Sep; 43(6):572-580. PubMed ID: 28476066
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand disease-associated angiodysplasia: a few answers, still many questions.
Franchini M; Mannucci PM
Br J Haematol; 2013 Apr; 161(2):177-82. PubMed ID: 23432086
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal angiodysplasia and bleeding in von Willebrand disease.
Franchini M; Mannucci PM
Thromb Haemost; 2014 Sep; 112(3):427-31. PubMed ID: 24898873
[TBL] [Abstract][Full Text] [Related]
17. von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor.
Brehm MA; Huck V; Aponte-Santamaría C; Obser T; Grässle S; Oyen F; Budde U; Schneppenheim S; Baldauf C; Gräter F; Schneider SW; Schneppenheim R
Thromb Haemost; 2014 Jul; 112(1):96-108. PubMed ID: 24598842
[TBL] [Abstract][Full Text] [Related]
18. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
de Romeuf C; Mazurier C
Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities in the Von Willebrand-Angiopoietin Axis Contribute to Dysregulated Angiogenesis and Angiodysplasia in Children With a Glenn Circulation.
Bartoli CR; Hennessy-Strahs S; Dowling RD; Gaynor JW; Glatz AC
JACC Basic Transl Sci; 2021 Mar; 6(3):222-235. PubMed ID: 33778210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
